BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 285 filers reported holding BIONTECH SE in Q4 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $313,688 | +7.0% | 3,904 | +22.9% | 0.10% | +1.9% |
| Q1 2024 | $293,036 | -6.3% | 3,177 | +7.2% | 0.10% | -17.6% |
| Q4 2023 | $312,877 | +2.1% | 2,965 | +5.1% | 0.12% | -9.4% |
| Q3 2023 | $306,532 | +9.2% | 2,822 | +8.5% | 0.14% | +12.2% |
| Q2 2023 | $280,784 | -1.1% | 2,602 | +14.2% | 0.12% | -11.5% |
| Q1 2023 | $283,837 | -11.1% | 2,279 | +7.2% | 0.14% | -21.5% |
| Q4 2022 | $319,298 | +25.7% | 2,126 | +12.8% | 0.18% | +16.4% |
| Q3 2022 | $254,000 | -4.2% | 1,885 | +6.0% | 0.15% | +2.0% |
| Q2 2022 | $265,000 | -3.3% | 1,779 | +10.6% | 0.15% | +10.4% |
| Q1 2022 | $274,000 | -25.1% | 1,609 | +13.2% | 0.14% | -24.2% |
| Q4 2021 | $366,000 | -3.7% | 1,421 | +1.6% | 0.18% | -11.9% |
| Q3 2021 | $380,000 | +23.4% | 1,399 | +1.6% | 0.20% | +26.2% |
| Q2 2021 | $308,000 | – | 1,377 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $11,947,443 | 19.99% |
| Quinn Opportunity Partners LLC | 683,287 | $54,908,943 | 6.24% |
| Krensavage Asset Management, LLC | 132,293 | $10,631 | 4.88% |
| Crocodile Capital Partners GmbH | 29,586 | $2,377,531 | 3.78% |
| ALTRINSIC GLOBAL ADVISORS LLC | 676,219 | $54,340,958 | 2.42% |
| FLOSSBACH VON STORCH AG | 4,379,483 | $351,935,254 | 1.48% |
| Systrade AG | 10,000 | $803,600 | 1.38% |
| HARDING LOEVNER LP | 2,926,761 | $235,224,417 | 1.30% |
| CenterBook Partners LP | 206,234 | $16,572,964 | 1.03% |
| SECTORAL ASSET MANAGEMENT INC | 27,265 | $2,191,015 | 0.89% |